Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 186 articles: HTML format Text format

Single Articles

February 2012
1. MARUOKA D , Imazeki F, Arai M, Kanda T, et al
   Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up.
   J Viral Hepat. 2012;19:e97-e104.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GROVER VP , Pavese N, Koh SB, Wylezinska M, et al
   Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation.
   J Viral Hepat. 2012;19:e89-e96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BACHMETOV L , Gal-Tanamy M, Shapira A, Vorobeychik M, et al
   Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
   J Viral Hepat. 2012;19:e81-e88.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RANCE E , Tanner JE, Alfieri C
   Inhibition of IkappaB kinase by thalidomide increases hepatitis C virus RNA replication.
   J Viral Hepat. 2012;19:e73-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHI KQ , Cai XH, Xiao DD, Wu SJ, et al
   Tumour necrosis factor-alpha-857T allele reduces the risk of hepatitis B virus infection in an Asian population.
   J Viral Hepat. 2012;19:e66-e72.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WAIDMANN O , Bihrer V, Pleli T, Farnik H, et al
   Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection.
   J Viral Hepat. 2012;19:e58-65.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HSU CS , Liu CH, Wang CC, Tseng TC, et al
   Impact of hepatitis B virus infection on metabolic profiles and modifying factors.
   J Viral Hepat. 2012;19:e48-57.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KWON JH , Jang JW, Lee S, Lee J, et al
   Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B.
   J Viral Hepat. 2012;19:e41-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. VAN DE KLUNDERT MA , Cremer J, Kootstra NA, Boot HJ, et al
   Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients.
   J Viral Hepat. 2012;19:e34-40.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SHI CC , Tjwa ET, Biesta PJ, Boonstra A, et al
    Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells.
    J Viral Hepat. 2012;19:e26-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KAWAGUCHI T , Ide T, Itou M, Suetsugu M, et al
    Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review.
    J Viral Hepat. 2012;19:e220-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SRIVASTAVA A , Yachha SK, Poddar U
    Predictors of outcome in children with acute viral hepatitis and coagulopathy.
    J Viral Hepat. 2012;19:e194-201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GUPTA P , Jagya N, Pabhu SB, Durgapal H, et al
    Immunohistochemistry for the diagnosis of hepatitis E virus infection.
    J Viral Hepat. 2012;19:e177-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SEBASTIANI G , Tempesta D, Alberti A
    Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus.
    J Viral Hepat. 2012;19:e170-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ALMARIO CV , Vega M, Trooskin SB, Navarro VJ, et al
    Examining hepatitis c virus testing practices in primary care clinics.
    J Viral Hepat. 2012;19:e163-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHENG JC , Yeh YJ, Huang YH, Liang KH, et al
    Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C.
    J Viral Hepat. 2012;19:e154-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CALES P , Zarski JP, Marc Chapplain J, Bertrais S, et al
    Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry.
    J Viral Hepat. 2012;19:e143-e153.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HAYASHI N , Okanoue T, Tsubouchi H, Toyota J, et al
    Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C.
    J Viral Hepat. 2012;19:e134-e142.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MIKI D , Ohishi W, Ochi H, Hayes CN, et al
    Serum PAI-1 is a novel predictor for response to pegylated interferon-alpha-2b plus ribavirin therapy in chronic hepatitis C virus infection.
    J Viral Hepat. 2012;19:e126-e133.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CRAXI A , Koutsounas S, Ogurtsov P, Chemello L, et al
    Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response.
    J Viral Hepat. 2012;19:e120-e125.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. YAMADA I , Suzuki F, Kamiya N, Aoki K, et al
    Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection.
    J Viral Hepat. 2012;19:e112-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HO EY , Ha NB, Ahmed A, Ayoub W, et al
    Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients.
    J Viral Hepat. 2012;19:e105-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. XIAO C , Qin B, Chen L, Liu H, et al
    Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus.
    J Viral Hepat. 2012;19:e1-e10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. COTLER SJ , Cotler S, Xie H, Luc BJ, et al
    Characterizing hepatitis B stigma in Chinese immigrants.
    J Viral Hepat. 2012;19:147-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. KATSOUNAS A , Trippler M, Wang B, Polis M, et al
    CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-alpha therapy and toll-like receptor 3 signalling.
    J Viral Hepat. 2012;19:128-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. VERMEHREN J , Susser S, Lange CM, Forestier N, et al
    Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b.
    J Viral Hepat. 2012;19:120-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. JAFFERBHOY H , Miller MH, Dunbar JK, Tait J, et al
    Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection.
    J Viral Hepat. 2012;19:112-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. REAU N , Hamzeh FM, Lentz E, Zhou X, et al
    Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.
    J Viral Hepat. 2012;19:94-102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ALAVIAN SM , Tabatabaei SV, Behnava B
    Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis.
    J Viral Hepat. 2012;19:88-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. STICKEL F , Helbling B, Heim M, Geier A, et al
    Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C.
    J Viral Hepat. 2012;19:77-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
31. CERAN N , Yuksel Kocdogan F, Mert D, Erdem I, et al
    Hepatitis a seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors.
    J Viral Hepat. 2012;19:72-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ALBERSTEIN M , Zornitzki T, Zick Y, Knobler H, et al
    Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.
    J Viral Hepat. 2012;19:65-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. HOPE V , Parry JV, Marongui A, Ncube F, et al
    Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference?
    J Viral Hepat. 2012;19:55-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. 
    A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East.
    J Viral Hepat. 2012;19:9-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. CIESEK S , Wedemeyer H
    Immunosuppression, liver injury and post-transplant HCV recurrence.
    J Viral Hepat. 2012;19:1-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KRONENBERGER B , Zeuzem S
    New developments in HCV therapy.
    J Viral Hepat. 2012;19 Suppl 1:48-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. NEGRO F
    Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:42-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. RUMI M , Aghemo A, Prati GM
    Comparative trials of peginterferon alpha2a and peginterferon alpha2b for chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:37-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SEBASTIANI G , Alberti A
    How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    J Viral Hepat. 2012;19 Suppl 1:18-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. SIMON-TALERO M , Buti M, Esteban R
    Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?
    J Viral Hepat. 2012;19 Suppl 1:14-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. FERENCI P
    Optimal treatment duration for patients with HCV genotype 1 infection.
    J Viral Hepat. 2012;19 Suppl 1:7-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. DEGASPERI E , Aghemo A
    Clinical drivers in naive patient eligibility for treatment of chronic hepatitis C.
    J Viral Hepat. 2012;19 Suppl 1:3-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
43. FABRIZI F , Dixit V, Martin P, Messa P, et al
    Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    J Viral Hepat. 2011;18:871-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. RYAN EJ , Stevenson NJ, Hegarty JE, O'Farrelly C, et al
    Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-alpha and stimulate T-cell proliferation.
    J Viral Hepat. 2011;18:840-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ALAVIAN SM , Ande SR, Coombs KM, Yeganeh B, et al
    Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development.
    J Viral Hepat. 2011;18:821-830.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
46. BARAKAT SH , El-Bashir N
    Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors.
    J Viral Hepat. 2011;18:779-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PROBST A , Dang T, Bochud M, Egger M, et al
    Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis.
    J Viral Hepat. 2011;18:745-759.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
48. LAUNAY O , Masurel J, Servant-Delmas A, Basse-Guerineau AL, et al
    High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    J Viral Hepat. 2011;18:721-729.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. DE ALMEIDA BS , Fabricio Silva GM, da Silva PM, de Mello Perez R, et al
    Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population.
    J Viral Hepat. 2011;18:692-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SANCHEZ-CONDE M , Miralles P, Maria Bellon J, Rincon D, et al
    Use of transient elastography (FibroScan((R)) ) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.
    J Viral Hepat. 2011;18:685-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. ESLAM M , Kawaguchi T, Del Campo JA, Sata M, et al
    Use of HOMA-IR in hepatitis C.
    J Viral Hepat. 2011;18:675-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HUSAIN MM , Aggarwal R, Kumar D, Jameel S, et al
    Effector T cells immune reactivity among patients with acute hepatitis E.
    J Viral Hepat. 2011;18:e603-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MUNSHI SU , Taneja S, Bhavesh NS, Shastri J, et al
    Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism.
    J Viral Hepat. 2011;18:e591-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. GENG J , Wang L, Wang X, Fu H, et al
    Potential risk of zoonotic transmission from young swine to human: seroepidemiological and genetic characterization of hepatitis E virus in human and various animals in Beijing, China.
    J Viral Hepat. 2011;18:e583-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. FRANCO S , Bellido R, Aparicio E, Canete N, et al
    Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.
    J Viral Hepat. 2011;18:e578-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. GHOSH S , Ahrens WA, Phatak SU, Hwang S, et al
    Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
    J Viral Hepat. 2011;18:e568-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. CHUNG H , Watanabe T, Kudo M, Chiba T, et al
    Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2011;18:e561-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. KAWAOKA T , Aikata H, Takaki S, Hiramatsu A, et al
    IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
    J Viral Hepat. 2011;18:e550-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ROQUE-CUELLAR MC , Sanchez B, Garcia-Lozano JR, Praena-Fernandez JM, et al
    Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    J Viral Hepat. 2011;18:e541-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ABDEL-HADY M , Bunn SK, Sira J, Brown RM, et al
    Chronic hepatitis C in children - review of natural history at a National Centre.
    J Viral Hepat. 2011;18:e535-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LIM AK , Patel N, Eckersley RJ, Fitzpatrick J, et al
    A comparison of (31) P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.
    J Viral Hepat. 2011;18:e530-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. YAO L , Dong H, Zhu H, Nelson D, et al
    Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.
    J Viral Hepat. 2011;18:e523-e529.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. NKONTCHOU G , Ziol M, Aout M, Lhabadie M, et al
    HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    J Viral Hepat. 2011;18:e516-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. TOGO S , Arai M, Tawada A, Chiba T, et al
    Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B.
    J Viral Hepat. 2011;18:e508-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. WILSON R , Warner N, Ryan K, Selleck L, et al
    The hepatitis B e antigen suppresses IL-1beta-mediated NF-kappaB activation in hepatocytes.
    J Viral Hepat. 2011;18:e499-507.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. TENG X , Liu JY, Li D, Fang Y, et al
    Application of allele-specific RNAi in hepatitis B virus lamivudine resistance.
    J Viral Hepat. 2011;18:e491-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. LIU CJ , Cheng HR, Chen CL, Chen TC, et al
    Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C.
    J Viral Hepat. 2011;18:e482-e490.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. PARK JW , Kim HS, Seo DD, Jang JS, et al
    Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance.
    J Viral Hepat. 2011;18:e475-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GRAMENZI A , Loggi E, Micco L, Cursaro C, et al
    Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
    J Viral Hepat. 2011;18:e468-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. GARCIA-FULGUEIRAS A , Garcia-Pina R, Morant C, Fernandez de Larrea-Baz N, et al
    Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.
    J Viral Hepat. 2011;18:e453-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. KIM HN , Scott J, Cent A, Cook L, et al
    HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.
    J Viral Hepat. 2011;18:e447-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. KWAK MS , Choi JW, Lee JS, Kim KA, et al
    Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir.
    J Viral Hepat. 2011;18:e432-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ZHENG JX , Zeng Z, Zheng YY, Yin SJ, et al
    Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    J Viral Hepat. 2011;18:e423-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. TRIPATHY AS , Das R, Chadha MS, Arankalle VA, et al
    Epidemic of Hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells.
    J Viral Hepat. 2011;18:e415-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. JANG JH , Jung YM, Kim JS, Lee SH, et al
    Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea.
    J Viral Hepat. 2011;18:e408-e414.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. TAPPER EB , Lau DT
    The need for clarity in occult HBV infection.
    J Viral Hepat. 2011;18:673-4.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
77. KE WM , Xie SB, Li XJ, Zhang SQ, et al
    There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma c
    J Viral Hepat. 2011;18:637-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. RYAN EJ , O'Farrelly C
    The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence.
    J Viral Hepat. 2011;18:601-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HATZAKIS A , Wait S, Bruix J, Buti M, et al
    The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    J Viral Hepat. 2011;18 Suppl 1:1-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. YUN MH , Seo YS, Kang HS, Lee KG, et al
    The effect of the respiratory cycle on liver stiffness values as measured by transient elastography.
    J Viral Hepat. 2011;18:631-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. GALMOZZI E , Del Menico B, Rametta R, Dongiovanni P, et al
    A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.
    J Viral Hepat. 2011;18:628-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
82. ENGLAND K , Thorne C, Harris H, Ramsay M, et al
    The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection.
    J Viral Hepat. 2011;18:533-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. STASI C , Zignego AL, Laffi G, Rosselli M, et al
    The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.
    J Viral Hepat. 2011;18:525-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. MOUCARI R , Boyer N, Ripault MP, Castelnau C, et al
    Sequential therapy with adefovir dipivoxil and pegylated interferon alfa-2a for HBeAg-negative patients.
    J Viral Hepat. 2011;18:580-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
85. DI MARTINO V , Crouzet J, Hillon P, Thevenot T, et al
    Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis.
    J Viral Hepat. 2011;18:493-505.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. HU X , Ma S, Huang X, Jiang X, et al
    Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease.
    J Viral Hepat. 2011;18:458-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. SONNEVELD MJ , Zoutendijk R, Janssen HL
    Hepatitis B surface antigen monitoring and management of chronic hepatitis B.
    J Viral Hepat. 2011;18:449-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. REDDICK KL , Jhaveri R, Gandhi M, James AH, et al
    Pregnancy outcomes associated with viral hepatitis.
    J Viral Hepat. 2011;18:e394-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. TANDON P , Doucette K, Fassbender K, Vandermeer B, et al
    Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation.
    J Viral Hepat. 2011;18:e381-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. PETTA S , Di Marco V, Di Stefano R, Cabibi D, et al
    TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1.
    J Viral Hepat. 2011;18:e372-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. COREY KE , Mendez-Navarro J, Barlow LL, Patwardhan V, et al
    Acute hepatitis C infection lowers serum lipid levels.
    J Viral Hepat. 2011;18:e366-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. VIGNIER N , Esmat G, Sharkawy AE, Hassany M, et al
    Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt.
    J Viral Hepat. 2011;18:e358-e365.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. RUIZ-MATEOS E , Machmach K, Romero-Sanchez MC, Ferrando-Martinez S, et al
    Hepatitis C virus replication in Caucasian HIV controllers.
    J Viral Hepat. 2011;18:e350-e357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. MOLLER JF , Moller B, Wiedenmann B, Berg T, et al
    CD154, a marker of antigen-specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection.
    J Viral Hepat. 2011;18:e341-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. COX J , Graves L, Marks E, Tremblay C, et al
    Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians.
    J Viral Hepat. 2011;18:e332-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. LINDH M , Lagging M, Arnholm B, Eilard A, et al
    IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.
    J Viral Hepat. 2011;18:e325-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. LEE JC , Tseng CK, Wu SF, Chang FR, et al
    San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.
    J Viral Hepat. 2011;18:e315-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. LOKO MA , Bani-Sadr F, Winnock M, Lacombe K, et al
    Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    J Viral Hepat. 2011;18:e307-e314.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. AHN DG , Shim SB, Moon JE, Kim JH, et al
    Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
    J Viral Hepat. 2011;18:e298-306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. ZHANG NP , Reijnders JG, Perquin M, Hansen BE, et al
     Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B.
     J Viral Hepat. 2011;18:e252-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. JI F , Yang B, Peng X, Ding H, et al
     Circulating microRNAs in hepatitis B virus-infected patients.
     J Viral Hepat. 2011;18:e242-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. THEIN HH , Walter SR, Gidding HF, Amin J, et al
     Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
     J Viral Hepat. 2011;18:e232-e241.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. LI T , Meng QH, Zou ZQ, Fan YC, et al
     Correlation between promoter methylation of glutathione-S-tranferase P1 and oxidative stress in acute-on-chronic hepatitis B liver failure.
     J Viral Hepat. 2011;18:e226-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. SANAI FM , Helmy A, Bzeizi KI, Babatin MA, et al
     Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
     J Viral Hepat. 2011;18:e217-e225.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. MIRANDOLA S , Campagnolo D, Bortoletto G, Franceschini L, et al
     Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
     J Viral Hepat. 2011;18:e212-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. FUNG J , Lai CL, Wong DK, Seto WK, et al
     Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
     J Viral Hepat. 2011;18:e200-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. NAKAZAWA T , Shibuya A, Takeuchi A, Shibata Y, et al
     Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
     J Viral Hepat. 2011;18:e191-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. AKKIZ H , Bayram S, Bekar A, Akgollu E, et al
     A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
     J Viral Hepat. 2011;18:e399-407.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. IPPOLITO AM , Niro GA, Fontana R, Lotti G, et al
     Unawareness of HBV infection among inpatients in a Southern Italian hospital.
     J Viral Hepat. 2011;18:e206-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. ZHANG X , Lin SM, Ye F, Chen TY, et al
     An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients.
     J Viral Hepat. 2011;18:e184-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. DETERDING K , Naesens L, Buti M, Janssen H, et al
     Adefovir serum levels do not differ between responders and nonresponders.
     J Viral Hepat. 2011;18:e175-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. WURSTHORN K , Zacher BJ, Jaroszewicz J, Darnedde M, et al
     Development of a protocol for the quantitative determination of HBeAg using the Elecsys(R) HBeAg immunoassay.
     J Viral Hepat. 2011;18:e179-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
113. MORIKAWA K , Lange CM, Gouttenoire J, Meylan E, et al
     Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
     J Viral Hepat. 2011;18:305-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
114. ARSHAD M , El-Kamary SS, Jhaveri R
     Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment?
     J Viral Hepat. 2011;18:229-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. LIU Y , Wang C, Zhong Y, Li X, et al
     Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.
     J Viral Hepat. 2011;18:e29-39.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. PRITCHETT S , Cardenas A, Manning D, Curry M, et al
     The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific.
     J Viral Hepat. 2011;18:e75-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. KIM JH , Yim HJ, Jung ES, Jung YK, et al
     Virologic and biochemical responses to clevudine in patients with chronic HBV infection-associated cirrhosis: data at week 48.
     J Viral Hepat. 2011;18:287-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. TILLMANN HL , Wiese M, Braun Y, Wiegand J, et al
     Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment.
     J Viral Hepat. 2011;18:252-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
119. PHAM TN , Coffin CS, Churchill ND, Urbanski SJ, et al
     Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.
     J Viral Hepat. 2011 Mar 1. doi: 10.1111/j.1365-2893.2011.01442.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
120. MOREL V , Fournier C, Francois C, Brochot E, et al
     Genetic recombination of the hepatitis C virus: clinical implications.
     J Viral Hepat. 2011;18:77-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
121. MIAILHES P , Pradat P, Chevallier M, Lacombe K, et al
     Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.
     J Viral Hepat. 2011;18:61-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. BLANCO F , Barreiro P, Ryan P, Vispo E, et al
     Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
     J Viral Hepat. 2011;18:11-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
123. AJMERA V , Xia G, Vaughan G, Forbi JC, et al
     What factors determine the severity of hepatitis A-related acute liver failure?
     J Viral Hepat. 2010 Dec 8. doi: 10.1111/j.1365-2893.2010.01410.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. KRUEGER C , Hawkins K, Wong S, Enns MW, et al
     Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression.
     J Viral Hepat. 2010 Dec 8. doi: 10.1111/j.1365-2893.2010.01408.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. COHEN C , Holmberg SD, McMahon BJ, Block JM, et al
     Is chronic hepatitis B being undertreated in the United States?
     J Viral Hepat. 2010 Dec 8. doi: 10.1111/j.1365-2893.2010.01401.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. GISH RG , Cooper SL
     Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic.
     J Viral Hepat. 2010 Dec 8. doi: 10.1111/j.1365-2893.2010.01382.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. LAWSON A
     A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients.
     J Viral Hepat. 2010 Dec 7. doi: 10.1111/j.1365-2893.2010.01406.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. MARTINEZ AD , Dimova R, Marks KM, Beeder AB, et al
     Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
     J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01411.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. KANDA T , Imazeki F, Yonemitsu Y, Mikami S, et al
     Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.
     J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01409.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. SANCHEZ-CONDE M , Montes Ramirez ML, Bellon Cano JM, Caminoa A, et al
     Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
     J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01407.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. UEDA Y , Marusawa H, Kaido T, Ogura Y, et al
     Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation.
     J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01398.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. TORNER N , Broner S, Martinez A, Godoy P, et al
     Hepatitis A outbreaks: the effect of a mass vaccination programme.
     J Viral Hepat. 2010 Dec 3. doi: 10.1111/j.1365-2893.2010.01395.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
133. BLOME MA , Bjorkman P, Flamholc L, Jacobsson H, et al
     Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
     J Viral Hepat. 2010 Nov 29. doi: 10.1111/j.1365-2893.2010.01400.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. VAN VLERKEN LG , Huisman EJ, Van Soest H, Boland GJ, et al
     Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients.
     J Viral Hepat. 2010 Nov 29. doi: 10.1111/j.1365-2893.2010.01399.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. ZAAIJER HL , Boot HJ, Van Swieten P, Koppelman MH, et al
     HBsAg-negative mono-infection with hepatitis B virus genotype G.
     J Viral Hepat. 2010 Nov 29. doi: 10.1111/j.1365-2893.2010.01397.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. ARANKALLE VA , Gandhi S, Lole KS, Chadha MS, et al
     An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes.
     J Viral Hepat. 2010 Nov 26. doi: 10.1111/j.1365-2893.2010.01391.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. FABRIZI F , Dixit V, Martin P, Messa P, et al
     Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
     J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01405.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. DERBALA MF , Amer AM, Almohanadi M, John A, et al
     Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
     J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01403.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. MUIR AJ , Hu KQ, Gordon SC, Koury K, et al
     Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
     J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01402.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. SUN SC , Bae A, Qi X, Harris J, et al
     Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naive HCV patient isolates.
     J Viral Hepat. 2010 Nov 25. doi: 10.1111/j.1365-2893.2010.01396.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. ZHOU YQ , Wang XH, Hong GH, Zhu Y, et al
     Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a.
     J Viral Hepat. 2010 Nov 24. doi: 10.1111/j.1365-2893.2010.01373.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. CLAUSEN LN , Weis N, Astvad K, Schonning K, et al
     Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort.
     J Viral Hepat. 2010 Nov 12. doi: 10.1111/j.1365-2893.2010.01392.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. RAMCHARRAN D , Wahed AS, Conjeevaram HS, Evans RW, et al
     Serum lipids and their associations with viral levels and liver disease severity in a treatment-naive chronic hepatitis C type 1-infected cohort.
     J Viral Hepat. 2010 Nov 10. doi: 10.1111/j.1365-2893.2010.01394.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. SOCKALINGAM S , Links PS, Abbey SE
     Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.
     J Viral Hepat. 2010 Nov 10. doi: 10.1111/j.1365-2893.2010.01393.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. LIANG XE , Chen YP, Zhang Q, Dai L, et al
     Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation.
     J Viral Hepat. 2010 Nov 9. doi: 10.1111/j.1365-2893.2010.01389.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. THURAIRAJAH P , Khanna A, Mutimer D
     Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (J Viral Hepat 2010 Feb 1;17(2):123-9).
     J Viral Hepat. 2010 Nov 5. doi: 10.1111/j.1365-2893.2010.01388.
     PubMed     Text format     Related articles   
     
     
     
     
147. LI HR , Huang JJ, Guo HQ, Zhang X, et al
     Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
     J Viral Hepat. 2010 Nov 5. doi: 10.1111/j.1365-2893.2010.01386.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. BERZSENYI MD , Roberts SK, Preiss S, Woollard DJ, et al
     Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-alpha in HCV & HCV/HIV infection.
     J Viral Hepat. 2010 Nov 3. doi: 10.1111/j.1365-2893.2010.01390.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
149. VIGANI AG , Macedo de Oliveira A, Tozzo R, Pavan MH, et al
     The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C.
     J Viral Hepat. 2010 Oct 25. doi: 10.1111/j.1365-2893.2010.01385.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. MCDONALD SA , Hutchinson SJ, Mills PR, Bird SM, et al
     The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.
     J Viral Hepat. 2010 Oct 22. doi: 10.1111/j.1365-2893.2010.01380.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. KUMTHIP K , Pantip C, Chusri P, Thongsawat S, et al
     Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.
     J Viral Hepat. 2010 Oct 19. doi: 10.1111/j.1365-2893.2010.01379.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. PARIKH M , Singh A, Sood G
     Extended treatment duration for treatment naive chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin.
     J Viral Hepat. 2010 Oct 18. doi: 10.1111/j.1365-2893.2010.01374.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. KRAUSKOPF K , McGinn TG, Federman AD, Halm EA, et al
     HIV and HCV health beliefs in an inner-city community.
     J Viral Hepat. 2010 Oct 18. doi: 10.1111/j.1365-2893.2010.01383.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. MCDONALD SA , Hutchinson SJ, Cameron S, Bird SM, et al
     Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007.
     J Viral Hepat. 2010 Oct 3. doi: 10.1111/j.1365-2893.2010.01377.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. CHOTIYAPUTTA W , Lok AS
     Endpoints of hepatitis B treatment.
     J Viral Hepat. 2010;17:675-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
156. AMINI-BAVIL-OLYAEE S , Herbers U, Luedde T, Trautwein C, et al
     Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
     J Viral Hepat. 2010 Sep 30. doi: 10.1111/j.1365-2893.2010.01378.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. MAUSS S , Hueppe D, John C, Goelz J, et al
     Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.
     J Viral Hepat. 2010 Sep 16. doi: 10.1111/j.1365-2893.2010.01372.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. GREBELY J , Bryant J, Hull P, Hopwood M, et al
     Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.
     J Viral Hepat. 2010 Sep 14. doi: 10.1111/j.1365-2893.2010.01370.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. WIEGAND J , Meya S, Schlaphoff V, Manns MP, et al
     HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.
     J Viral Hepat. 2010;17:631-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
160. ZHANG ZH , Li L, Zhao XP, Glebe D, et al
     Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. MARTIN-CARBONERO L , Tuma P, Vispo E, Medrano J, et al
     Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. WANG CS , Chang TT, Yao WJ, Wang ST, et al
     The impact of smoking on incident type 2 diabetes in a cohort with hepatitis B but not hepatitis C infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. FABRIZI F , Dixit V, Messa P, Martin P, et al
     Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. LOUIE KS , Micallef JM, Pimenta JM, Forssen UM, et al
     Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. GIANNINI EG , Savarino V
     Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eye.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. DE SCHRYVER A , Verstrepen K, Vandersmissen L, Vandermeeren N, et al
     Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. CHOTIYAPUTTA W , Degertekin B, McKenna BJ, Samala N, et al
     Characteristics of chronic hepatitis B patients who underwent liver biopsies.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. GIESELER RK , Marquitan G, Schlattjan M, Sowa JP, et al
     Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. YAMINI D , Basseri B, Chee GM, Arakelyan A, et al
     Tobacco and other factors have a negative impact on quality of life in hepatitis C patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. GUEDJ J , Rong L, Dahari H, Perelson AS, et al
     A perspective on modelling hepatitis C virus infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. OSIOWY C , Larke B, Giles E
     Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. YURDAYDIN C , Idilman R, Bozkaya H, Bozdayi AM, et al
     Natural history and treatment of chronic delta hepatitis.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. IWATA R , Stieger B, Mertens JC, Muller T, et al
     The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. BEERSMA MF , Verjans GM, Metselaar HJ, Osterhaus AD, et al
     Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. LANDI A , Yu H, Babiuk LA, van Drunen Littel-van den Hurk S, et al
     Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. ARAUJO ES , Dahari H, Neumann AU, de Paula Cavalheiro N, et al
     Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. SUTTI S , Vidali M, Mombello C, Sartori M, et al
     Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. BOODRAM B , Hershow RC, Klinzman D, Stapleton JT, et al
     GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
179. FUNG J , Lai CL, Seto WK, Wong DK, et al
     Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. IPPAGUNTA SK , Naik S, Jameel S, Ramana KN, et al
     Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. LAO XQ , Thompson A, McHutchison JG, McCarthy JJ, et al
     Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. WANG J , Zhou B, Lai Q, Wang Y, et al
     Clinical and virological characteristics of chronic hepatitis B with concurrent hepatitis B E antigen and antibody detection.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. ARANKALLE VA , Gandhe SS, Borkakoty BJ, Walimbe AM, et al
     A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India.
     J Viral Hepat. 2010;17:501-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. LUO K , Liu Z, Karayiannis P
     Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.
     J Viral Hepat. 2010;17:511-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
185. SOUTHERN WN , Drainoni ML, Smith BD, Christiansen CL, et al
     Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.
     J Viral Hepat. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. RENOU C , Lafeuillade A, Pavio N, Nicand E, et al
     Response to Madejon et al.: are HIV-infected patients at risk of HEV infection?
     J Viral Hepat. 2010;17:380.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: